Peaks of Interest
Thermo Fisher Scientific Partners with China Doping Control Center; Millipore to Provide "Stem Cell Tested" Products; Hood Wins Pittcon Heritage Award
Thermo Fisher Scientific Partners with China Doping Control Center
Thermo Fisher Scientific, Inc. (Waltham, MA) announces that the China Doping Control Center (CDCC) has selected Thermo Scientific instruments and software for its sports testing program at the 29th Olympic Games in Beijing. The CDCC has been accredited by the Chinese government and the International Olympic Committee (IOC) to conduct all doping control analyses during the 2008 Olympic Games.
Thermo Fisher provided the CDCC with a range of high precision and performance Thermo Scientific instrumentation, including two GC–MS systems, a mass spectrometer, and four triple-quadrupole TSQ Quantum Access LC–MS systems. These instruments and associated software will enable the CDCC to cope with the high volume of samples expected at the 2008 Olympic Games. Thermo Fisher has also agreed to provide 24/7 technical and application assistance to the CDCC to ensure uninterrupted operation and successful, secure handling of athlete samples throughout the games.
Millipore to Provide "Stem Cell Tested" Products
Millipore Corporation (Billerica, Massachusetts) announced its initiative to provide "Stem Cell Tested" products. Many of Millipore's filter products will be validated for use on stem cells. A membrane developed by Millipore is the first available under this initiative.
The company's filter cups combine a filter unit with a receiver flask and cap for processing and storage. Supplied sterile and ready-to-use, the Stericup offers fast flow with high throughput and low protein binding ensures key growth factors and proteins are not absorbed.
Hood Wins Pittcon Heritage Award
The 2008 Pittcon Heritage Award will be presented to Dr. Leroy Hood, President of the Institute for Systems Biology. The award will be presented in the Opening Session, which begins at 4:30 p.m. on March 2, immediately followed by the Plenary Lecture, Systems Biology and Systems Medicine, also presented by Dr. Hoo.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
